Document Report Card

Basic Information

ID: ALA1759899

Journal: Bioorg Med Chem Lett

Title: Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles.

Authors: Nguyen JT, Kato K, Hidaka K, Kumada HO, Kimura T, Kiso Y.

Abstract: The human T cell leukemia/lymphotropic virus type 1 (HTLV-I) is clinically associated with adult T cell leukemia/lymphoma, HTLV-I associated myelopathy/tropical spastic paraparesis, and a number of other chronic inflammatory diseases. To stop the replication of the virus, we developed highly potent tetrapeptidic HTLV-I protease inhibitors. In a recent X-ray crystallography study, several of our inhibitors could not form co-crystal complexes with the protease due to their high hydrophobicity. In the current study, we designed, synthesized and evaluated the HTLV-I protease inhibition potency of compounds with hydrophilic end-capping moieties with the aim of improving pharmaceutic and pharmacokinetic properties.

CiteXplore: 21392990

DOI: 10.1016/j.bmcl.2011.02.066